These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18626549)

  • 21. Tumor associated macrophages: predicting bacillus Calmette-Guerin immunotherapy outcomes.
    Brandau S
    J Urol; 2009 Apr; 181(4):1532-3. PubMed ID: 19230928
    [No Abstract]   [Full Text] [Related]  

  • 22. [BCG immunotherapy and vulgar warts].
    Palou J; Sánchez J; Laguna P
    Actas Urol Esp; 1996; 20(10):928-9. PubMed ID: 9139541
    [No Abstract]   [Full Text] [Related]  

  • 23. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy.
    Dudelzak J; Curtis AR; Sheehan DJ; Lesher JL
    J Drugs Dermatol; 2008 Jul; 7(7):684. PubMed ID: 18664162
    [No Abstract]   [Full Text] [Related]  

  • 24. Tuberculosis of the skin: historical perspectives on tuberculin and Bacille Calmette Guérin.
    Beutner EH
    Int J Dermatol; 1997 Jan; 36(1):73-7. PubMed ID: 9071626
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story: H. W. Herr and A. Morales. J Urol 2008; 179: 53-56.
    Koyama A
    J Urol; 2008 Nov; 180(5):2255; author reply 2255. PubMed ID: 18823917
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacille Calmette-Guérin vaccination: the current situation in Europe.
    Dara M; Acosta CD; Rusovich V; Zellweger JP; Centis R; Migliori GB;
    Eur Respir J; 2014 Jan; 43(1):24-35. PubMed ID: 24381321
    [No Abstract]   [Full Text] [Related]  

  • 27. Improvement of bladder cancer immunotherapy by creating a recombinant Bacille Calmette-Gu'erin which secrets p53 protein.
    Amirkhah R; Khanahmad H; Abolhassani M; Pooya M; Movassagh H; Shokrgozar MA
    Med Hypotheses; 2009 Jun; 72(6):754. PubMed ID: 19264423
    [No Abstract]   [Full Text] [Related]  

  • 28. More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4.
    Qie YQ; Wang JL; Liu W; Shen H; Chen JZ; Zhu BD; Xu Y; Zhang XL; Wang HH
    Scand J Immunol; 2009 Apr; 69(4):342-50. PubMed ID: 19284499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of viable BCG vaccine paste in the treatment of common warts: a double-blind randomized control trial.
    Yaghoobi R; Soghrati M; Tavakoli S; Pazyar N; Abounoori M; Abounoori A; Houshmand G
    J Dermatolog Treat; 2022 Jun; 33(4):2198-2202. PubMed ID: 34060416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunotherapy with BCG in pulmonary tumors].
    Tanzj PL
    Minerva Med; 1976 Dec; 67(63):4167-72. PubMed ID: 1018810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacille Calmette-Guérin vaccinations and tuberculin skin tests.
    Snider DE
    JAMA; 1985 Jun; 253(23):3438-9. PubMed ID: 3999327
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
    Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
    J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methodological issues in estimating the annual risk of tuberculosis infection in Indonesia.
    Muula AS; Bachtiar A; Mehta F; Chadha VK
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1218; author reply 1218-9. PubMed ID: 18812055
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of various tuberculosis screening strategies based on tuberculin testing in schoolchildren in Paris].
    Lévy-Bruhl D; Mallet HP; Strady C; Larnaudie S
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):253-9. PubMed ID: 18687540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy?
    Gofrit ON; Pode D; Pizov G; Zorn KC; Katz R; Shapiro A
    BJU Int; 2009 Apr; 103(7):905-8. PubMed ID: 19021623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].
    Yildirim C; Küçük AI; Ongüt G; Oğünç D; Colak D; Mutlu G
    Mikrobiyol Bul; 2009 Jan; 43(1):27-35. PubMed ID: 19334377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
    Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intradermal reaction to tuberculin (IDR) or tuberculin test].
    Rev Mal Respir; 2003 Dec; 20(6 Pt 2):S27-33. PubMed ID: 15101327
    [No Abstract]   [Full Text] [Related]  

  • 40. Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigens.
    Garip A; Diedrichs-Möhring M; Thurau SR; Deeg CA; Wildner G
    Ophthalmology; 2009 Dec; 116(12):2457-62.e1-2. PubMed ID: 19815288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.